Amedica (AMDA) Misses Q3 EPS by 9c

Amedica (NASDAQ: AMDA) reported Q3 EPS of ($0.15), $0.09 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $4.8 million versus the consensus estimate of $5 million.

For earnings history and earnings-related data on Amedica (AMDA) click here.

You May Also Be Interested In

• Burry doubles down on Nebius short after stock surges 34% on earnings
• Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
• Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c